[Calcium channel blocker for therapy of patients with hypertension].
Nihon Rinsho
; 55(8): 2061-6, 1997 Aug.
Article
em Ja
| MEDLINE
| ID: mdl-9284424
ABSTRACT
Calcium channel blocker (CCB) is one of the most frequently prescribed cardiovascular drugs. Two main classes of CCBs, dihydropyridines and benzothiazepines, are now clinically available for the treatment of hypertension in Japan. Both drugs inhibit the inward current of calcium ions through the L-type calcium channels. However CCBs have markedly different chemical structures and different effects on cardiovascular system. Therefore, in the present paper, their pharmacokinetic properties and interactions with other drugs are reviewed, and newly developed CCB are also described.
Buscar no Google
Base de dados:
MEDLINE
Métodos Terapêuticos e Terapias MTCI:
Terapias_biologicas
/
Aromoterapia
Assunto principal:
Bloqueadores dos Canais de Cálcio
/
Hipertensão
Idioma:
Ja
Revista:
Nihon Rinsho
Ano de publicação:
1997
Tipo de documento:
Article